Back to Top
World Gastroenterology Organisation
World Gastroenterology Organisation
WGO: Facebook WGO: Twitter


Level: Meta-analyses, Systematic reviews, Practice guidelines: 74 Abstracts

Legend: : Key Development,  : Very Important,  : Important, [no star]: Special Mention


Mechanisms of obesity-induced gastrointestinal neoplasia.
Alemán JO(1), Eusebi LH(2), Ricciardiello L(3), Patidar K(4), Sanyal AJ(4), Holt PR(5)., Gastroenterology. 2014 Feb;146(2):357-73. doi: 10.1053/j.gastro.2013.11.051. Epub 2013 Dec 6.


Taste receptors of the gut: emerging roles in health and disease.
Depoortere I., Gut. 2014 Jan;63(1):179-90. doi: 10.1136/gutjnl-2013-305112. Epub 2013 Oct 16.


Insight into the prebiotic concept: lessons from an exploratory, double blindintervention study with inulin-type fructans in obese women.
Dewulf EM(1), Cani PD, Claus SP, Fuentes S, Puylaert PG, Neyrinck AM, Bindels LB,de Vos WM, Gibson GR, Thissen JP, Delzenne NM., Gut. 2013 Aug;62(8):1112-21. doi: 10.1136/gutjnl-2012-303304. Epub 2012 Nov 7.

Comments: Double blind intervention study with inulin-type fructans in obese women, led to an increase in Bifidobacterium and Faecalibacterium prausnitzii, and a decrease of Bacteroides intestinalis, Bacteroides vulgatus and Propionibacterium, an effect associated with a slight decrease in fat mass.


Weight change and health outcomes at 3 years after bariatric surgery amongindividuals with severe obesity.
Courcoulas AP(1), Christian NJ, Belle SH, Berk PD, Flum DR, Garcia L, Horlick M, Kalarchian MA, King WC, Mitchell JE, Patterson EJ, Pender JR, Pomp A, Pories WJ, Thirlby RC, Yanovski SZ, Wolfe BM; Longitudinal Assessment of Bariatric Surgery (LABS) Consortium., JAMA. 2013 Dec 11;310(22):2416-25. doi: 10.1001/jama.2013.280928.

Comments: Three years after surgery, median actual weight loss for Roux-en-Y gastric bypass (RYGB) was 31.5%, remission of diabetes 67%, of dislipidemia 62% and of hypertension 38%, for laparoscopic adjustable gastric banding (LAGB) 16%, 29%, 27% and 17% respect.


Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes.
Look AHEAD Research Group, Wing RR, Bolin P, Brancati FL, Bray GA, Clark JM,Coday M, Crow RS, Curtis JM, Egan CM, Espeland MA, Evans M, Foreyt JP, Ghazarian S, Gregg EW, Harrison B, Hazuda HP, Hill JO, Horton ES, Hubbard VS, Jakicic JM,Jeffery RW, Johnson KC, Kahn SE, Kitabchi AE, Knowler WC, Lewis CE, Maschak-CareyBJ, Montez MG, Murillo A, Nathan DM, Patricio J, Peters A, Pi-Sunyer X, PownallH, Reboussin D, Regensteiner JG, Rickman AD, Ryan DH, Safford M, Wadden TA,Wagenknecht LE, West DS, Williamson DF, Yanovski SZ., N Engl J Med. 2013 Jul 11;369(2):145-54. doi: 10.1056/NEJMoa1212914. Epub 2013 Jun 24.

Comments: The intensive lifestyle intervention produced greater reductions in weight, in glycated hemoglobin and improvements in fitness and all cardiovascular risk factors, but no reduction in LDL-cholesterol nor in cardiovascular events.


Inflammation, autophagy, and obesity: common features in the pathogenesis of pancreatitis and pancreatic cancer.
Gukovsky I, Li N, Todoric J, Gukovskaya A, Karin M. Gastroenterology. 2013 Jun;144(6):1199-209.e4. doi: 10.1053/j.gastro.2013.02.007. PubMed PMID: 23622129.


Body mass index category as a risk factor for colorectal adenomas: a systematicreview and meta-analysis.
Okabayashi K, Ashrafian H, Hasegawa H, Yoo JH, Patel VM, Harling L, Rowland SP,Ali M, Kitagawa Y, Darzi A, Athanasiou T., Am J Gastroenterol. 2012 Aug;107(8):1175-85; quiz 1186. doi:10.1038/ajg.2012.180. Epub 2012 Jun 26.


The effectiveness and cost effectiveness of dark chocolate consumption as prevention therapy in people at high risk of cardiovascular disease: best casescenario analysis using a Markov model.
Zomer E, Owen A, Magliano DJ, Liew D, Reid CM., BMJ. 2012 May 30;344:e3657. doi: 10.1136/bmj.e3657.


Bariatric surgery versus conventional medical therapy for type 2 diabetes.
Mingrone G, Panunzi S, De Gaetano A, Guidone C, Iaconelli A, Leccesi L, Nanni G, Pomp A, Castagneto M, Ghirlanda G, Rubino F., N Engl J Med. 2012 Apr 26;366(17):1577-85. doi: 10.1056/NEJMoa1200111. Epub 2012 Mar 26.


Randomized trial of exercise effect on intrahepatic triglyceride content and lipid kinetics in nonalcoholic fatty liver disease.
Sullivan S, Kirk EP, Mittendorfer B, Patterson BW, Klein S., Hepatology. 2012 Jun;55(6):1738-45. doi: 10.1002/hep.25548. Epub 2012 Apr 25.


Weight Loss and Health Status 3 Years after Bariatric Surgery in Adolescents.
Inge TH, Courcoulas AP, Jenkins TM, Michalsky MP, Helmrath MA, Brandt ML, Harmon CM, Zeller MH, Chen MK, Xanthakos SA, Horlick M, Buncher CR; Teen-LABS Consortium., N Engl J Med. 2016 Jan 14;374(2):113-23. doi: 10.1056/NEJMoa1506699. Epub 2015 Nov 6.


Effects of total fat intake on body weight.
Hooper L, Abdelhamid A, Bunn D, Brown T, Summerbell CD, Skeaff CM., Cochrane Database Syst Rev. 2015 Aug 7;8:CD011834. doi: 10.1002/14651858.CD011834. Review.


Behavioral counseling to promote a healthful diet and physical activity for cardiovascular disease prevention in adults with cardiovascular risk factors: U.S. Preventive Services Task Force Recommendation Statement.
LeFevre ML; U.S. Preventive Services Task Force., Ann Intern Med. 2014 Oct 21;161(8):587-93. doi: 10.7326/M14-1796.
Comments: Recommendations in CVD


Maternal and child undernutrition and overweight in low-income and middle-income countries.
Black RE(1), Victora CG, Walker SP, Bhutta ZA, Christian P, de Onis M, Ezzati M, Grantham-McGregor S, Katz J, Martorell R, Uauy R; Maternal and Child NutritionStudy Group., Lancet. 2013 Aug 3;382(9890):427-51. doi: 10.1016/S0140-6736(13)60937-X. Epub2013 Jun 6.


Evolving importance of kidney disease: from subspecialty to global health burden.
Eckardt KU(1), Coresh J, Devuyst O, Johnson RJ, Köttgen A, Levey AS, Levin A., Lancet. 2013 Jul 13;382(9887):158-69. doi: 10.1016/S0140-6736(13)60439-0. Epub2013 May 31.


Bariatric surgery for weight loss and glycemic control in nonmorbidly obese adults with diabetes: a systematic review.
Maggard-Gibbons M, Maglione M, Livhits M, Ewing B, Maher AR, Hu J, Li Z, Shekelle PG. JAMA. 2013 Jun 5;309(21):2250-61. doi: 10.1001/jama.2013.4851. PubMed PMID: 23736734.


Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the Diabetes Surgery Study randomized clinical trial.
Ikramuddin S, Korner J, Lee WJ, Connett JE, Inabnet WB, Billington CJ, Thomas AJ, Leslie DB, Chong K, Jeffery RW, Ahmed L, Vella A, Chuang LM, Bessler M, Sarr MG, Swain JM, Laqua P, Jensen MD, Bantle JP. JAMA. 2013 Jun 5;309(21):2240-9. doi: 10.1001/jama.2013.5835. PubMed PMID: 23736733.


Individual- versus group-based financial incentives for weight loss: a randomized, controlled trial.
Kullgren JT, Troxel AB, Loewenstein G, Asch DA, Norton LA, Wesby L, Tao Y, Zhu J, Volpp KG. Ann Intern Med. 2013 Apr 2;158(7):505-14. doi: 10.7326/0003-4819-158-7-201304020-00002. PubMed PMID: 23546562.


A behavioral weight-loss intervention in persons with serious mental illness.
Daumit GL, Dickerson FB, Wang NY, Dalcin A, Jerome GJ, Anderson CA, Young DR, Frick KD, Yu A, Gennusa JV 3rd, Oefinger M, Crum RM, Charleston J, Casagrande SS, Guallar E, Goldberg RW, Campbell LM, Appel LJ. N Engl J Med. 2013 Apr 25;368(17):1594-602. doi: 10.1056/NEJMoa1214530. Epub 2013 Mar 21. PubMed PMID: 23517118.


A critical appraisal of advances in pediatric nonalcoholic Fatty liver disease.
Ovchinsky N, Lavine JE. Semin Liver Dis. 2012 Nov;32(4):317-24. doi: 10.1055/s-0032-1329905. Epub 2013 Feb 8. PubMed PMID: 23397532.


Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis.
Flegal KM, Kit BK, Orpana H, Graubard BI. JAMA. 2013 Jan 2;309(1):71-82. doi: 10.1001/jama.2012.113905. PubMed PMID: 23280227.


CYP2E1 and oxidant stress in alcoholic and non-alcoholic fatty liver disease.
Leung TM, Nieto N., J Hepatol. 2013 Feb;58(2):395-8. doi: 10.1016/j.jhep.2012.08.018. Epub 2012 Aug28.


Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects.
Carlsson LM, Peltonen M, Ahlin S, Anveden Å, Bouchard C, Carlsson B, Jacobson P, Lönroth H, Maglio C, Näslund I, Pirazzi C, Romeo S, Sjöholm K, Sjöström E, Wedel H, Svensson PA, Sjöström L., N Engl J Med. 2012 Aug 23;367(8):695-704. doi: 10.1056/NEJMoa1112082.


Effects of dietary composition on energy expenditure during weight-lossmaintenance.
Ebbeling CB, Swain JF, Feldman HA, Wong WW, Hachey DL, Garcia-Lago E, Ludwig DS., JAMA. 2012 Jun 27;307(24):2627-34. doi: 10.1001/jama.2012.6607.


Lifestyle change and mobility in obese adults with type 2 diabetes.
Rejeski WJ, Ip EH, Bertoni AG, Bray GA, Evans G, Gregg EW, Zhang Q; Look AHEADResearch Group., N Engl J Med. 2012 Mar 29;366(13):1209-17. doi: 10.1056/NEJMoa1110294.


Bariatric surgery versus intensive medical therapy in obese patients withdiabetes.
Schauer PR, Kashyap SR, Wolski K, Brethauer SA, Kirwan JP, Pothier CE, Thomas S, Abood B, Nissen SE, Bhatt DL., N Engl J Med. 2012 Apr 26;366(17):1567-76. doi: 10.1056/NEJMoa1200225. Epub 2012 Mar 26.


Are common factors involved in the pathogenesis of primary liver cancers? Ameta-analysis of risk factors for intrahepatic cholangiocarcinoma.
Palmer WC, Patel T., J Hepatol. 2012 Jul;57(1):69-76. doi: 10.1016/j.jhep.2012.02.022. Epub 2012 Mar13.


Exercise and non-alcoholic fatty liver disease: a systematic review andmeta-analysis.
Keating SE, Hackett DA, George J, Johnson NA., J Hepatol. 2012 Jul;57(1):157-66. doi: 10.1016/j.jhep.2012.02.023. Epub 2012 Mar 10.


Trial of prevention and reduction of obesity through active living in clinicalsettings: a randomized controlled trial.
Ross R, Lam M, Blair SN, Church TS, Godwin M, Hotz SB, Johnson A, Katzmarzyk PT, Lévesque L, MacDonald S., Arch Intern Med. 2012 Mar 12;172(5):414-24. doi: 10.1001/archinternmed.2011.1972.Epub 2012 Feb 27.


Bariatric surgery and long-term cardiovascular events.
Sjöström L, Peltonen M, Jacobson P, Sjöström CD, Karason K, Wedel H, Ahlin S, Anveden Å, Bengtsson C, Bergmark G, Bouchard C, Carlsson B, Dahlgren S, Karlsson J, Lindroos AK, Lönroth H, Narbro K, Näslund I, Olbers T, Svensson PA, Carlsson LM., JAMA. 2012 Jan 4;307(1):56-65. doi: 10.1001/jama.2011.1914.


Discordance in fibrosis staging between liver biopsy and transient elastographyusing the FibroScan XL probe.
Myers RP, Pomier-Layrargues G, Kirsch R, Pollett A, Beaton M, Levstik M,Duarte-Rojo A, Wong D, Crotty P, Elkashab M., J Hepatol. 2012 Mar;56(3):564-70. doi: 10.1016/j.jhep.2011.10.007. Epub 2011 Oct 23.


Omega-3 supplementation and non-alcoholic fatty liver disease: a systematicreview and meta-analysis.
Parker HM, Johnson NA, Burdon CA, Cohn JS, O'Connor HT, George J., J Hepatol. 2012 Apr;56(4):944-51. doi: 10.1016/j.jhep.2011.08.018. Epub 2011 Oct 21.


Feasibility and diagnostic performance of the FibroScan XL probe for liverstiffness measurement in overweight and obese patients.
Myers RP, Pomier-Layrargues G, Kirsch R, Pollett A, Duarte-Rojo A, Wong D, BeatonM, Levstik M, Crotty P, Elkashab M., Hepatology. 2012 Jan;55(1):199-208. doi: 10.1002/hep.24624. Epub 2011 Nov 18.


Separate and combined associations of body-mass index and abdominal adipositywith cardiovascular disease: collaborative analysis of 58 prospective studies.
Emerging Risk Factors Collaboration, Wormser D, Kaptoge S, Di Angelantonio E,Wood AM, Pennells L, Thompson A, Sarwar N, Kizer JR, Lawlor DA, Nordestgaard BG, Ridker P, Salomaa V, Stevens J, Woodward M, Sattar N, Collins R, Thompson SG,Whitlock G, Danesh J., Lancet. 2011 Mar 26;377(9771):1085-95.


Systematic review: the effects of conservative and surgical treatment for obesity on gastro-oesophageal reflux disease.
De Groot NL, Burgerhart JS, Van De Meeberg PC, de Vries DR, Smout AJ, Siersema PD, Aliment Pharmacol Ther. 2009 Dec 1;30(11-12):1091-102


Long-term drug treatment for obesity: a systematic and clinical review.
Yanovski SZ(1), Yanovski JA(2)., JAMA. 2014 Jan 1;311(1):74-86. doi: 10.1001/jama.2013.281361.


Pathophysiology and treatment of type 2 diabetes: perspectives on the past,present, and future.
Kahn SE(1), Cooper ME(2), Del Prato S(3)., Lancet. 2014 Mar 22;383(9922):1068-83. doi: 10.1016/S0140-6736(13)62154-6. Epub 2013 Dec 3.


Metabolic mediators of the effects of body-mass index, overweight, and obesity oncoronary heart disease and stroke: a pooled analysis of 97 prospective cohortswith 1·8 million participants.
Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration (BMIMediated Effects), Lu Y, Hajifathalian K, Ezzati M, Woodward M, Rimm EB, Danaei G., Lancet. 2014 Mar 15;383(9921):970-83. doi: 10.1016/S0140-6736(13)61836-X. Epub 2013 Nov 22.

Comments: Interventions that reduce high blood pressure, cholesterol, and glucose might address about half of excess risk of coronary heart disease and three-quarters of excess risk of stroke associated with high BMI. Maintenance of optimum bodyweight is needed for the full benefits.


Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: a randomized clinicaltrial.
Abed HS(1), Wittert GA, Leong DP, Shirazi MG, Bahrami B, Middeldorp ME, LorimerMF, Lau DH, Antic NA, Brooks AG, Abhayaratna WP, Kalman JM, Sanders P., JAMA. 2013 Nov 20;310(19):2050-60. doi: 10.1001/jama.2013.280521.

Comments: The intervention group showed a significantly greater reduction in weight and in atrial fibrillation symptom burden.


Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials.
Gloy VL(1), Briel M, Bhatt DL, Kashyap SR, Schauer PR, Mingrone G, Bucher HC,Nordmann AJ., BMJ. 2013 Oct 22;347:f5934. doi: 10.1136/bmj.f5934.

Comments: Meta-analysis of 11 studies: Compared with non-surgical treatment, bariatric surgery led to greater loss of body weight (mean difference -26 kg) remission of diabetes, triglyceride concentrations (-0.7 mmol/L) and increase in HDL-cholesterol (+ 0.21 mmol/L). Changes in blood pressure and LDL-cholesterol concentrations were not significantly different. A common adverse event was iron deficiency anaemia (15% in malabsorptive) and reoperations (8%).


Chronic use of opioid medications before and after bariatric surgery.
Raebel MA(1), Newcomer SR, Reifler LM, Boudreau D, Elliott TE, DeBar L, Ahmed A, Pawloski PA, Fisher D, Donahoo WT, Bayliss EA., JAMA. 2013 Oct 2;310(13):1369-76. doi: 10.1001/jama.2013.278344.

Comments: In this cohort of patients who underwent bariatric surgery, 77% of patients who were chronic opioid users before surgery continued chronic opioid use in the year following surgery, and the amount of chronic opioid use was greater postoperatively than preoperatively. 


Recommendations for growth monitoring, and prevention and management of overweight and obesity in children and youth in primary care.
Canadian Task Force on Preventive Health Care., CMAJ. 2015 Apr 7;187(6):411-21. doi: 10.1503/cmaj.141285. Epub 2015 Mar 30. No abstract available.


Identification, assessment, and management of overweight and obesity: summary of updated NICE guidance.
Stegenga H, Haines A, Jones K, Wilding J; Guideline Development Group., BMJ. 2014 Nov 27;349:g6608. doi: 10.1136/bmj.g6608. No abstract available.


Effects of promoting longer-term and exclusive breastfeeding on adiposity and insulin-like growth factor-I at age 11.5 years: a randomized trial.
Martin RM, Patel R, Kramer MS, Guthrie L, Vilchuck K, Bogdanovich N, Sergeichick N, Gusina N, Foo Y, Palmer T, Rifas-Shiman SL, Gillman MW, Smith GD, Oken E. JAMA. 2013 Mar 13;309(10):1005-13. doi: 10.1001/jama.2013.167. PubMed PMID: 23483175.


School-based physical activity programs for promoting physical activity and fitness in children and adolescents aged 6 to 18.
Dobbins M, Husson H, DeCorby K, LaRocca RL. Cochrane Database Syst Rev. 2013 Feb 28;2:CD007651. doi: 10.1002/14651858.CD007651.pub2. PubMed PMID: 23450577.


Antenatal interventions for reducing weight in obese women for improving pregnancy outcome.
Furber CM, McGowan L, Bower P, Kontopantelis E, Quenby S, Lavender T. Cochrane Database Syst Rev. 2013 Jan 31;1:CD009334. doi: 10.1002/14651858.CD009334.pub2. PubMed PMID: 23440836.


Macrosomia in 23 developing countries: an analysis of a multicountry, facility-based, cross-sectional survey.
Koyanagi A, Zhang J, Dagvadorj A, Hirayama F, Shibuya K, Souza JP, Gülmezoglu AM. Lancet. 2013 Feb 9;381(9865):476-83. doi: 10.1016/S0140-6736(12)61605-5. Epub 2013 Jan 4. PubMed PMID: 23290494.


Association of an intensive lifestyle intervention with remission of type 2 diabetes.
Gregg EW, Chen H, Wagenknecht LE, Clark JM, Delahanty LM, Bantle J, Pownall HJ, Johnson KC, Safford MM, Kitabchi AE, Pi-Sunyer FX, Wing RR, Bertoni AG; Look AHEAD Research Group. JAMA. 2012 Dec 19;308(23):2489-96. doi: 10.1001/jama.2012.67929. PubMed PMID: 23288372.


Effects of fructose vs glucose on regional cerebral blood flow in brain regions involved with appetite and reward pathways.
Page KA, Chan O, Arora J, Belfort-Deaguiar R, Dzuira J, Roehmholdt B, Cline GW, Naik S, Sinha R, Constable RT, Sherwin RS. JAMA. 2013 Jan 2;309(1):63-70. doi: 10.1001/jama.2012.116975. PubMed PMID: 23280226.


Prevalence of and risk factors for autopsy-determined atherosclerosis among US service members, 2001-2011.
Webber BJ, Seguin PG, Burnett DG, Clark LL, Otto JL. JAMA. 2012 Dec 26;308(24):2577-83. doi: 10.1001/jama.2012.70830. PubMed PMID: 3268516.


Green tea for weight loss and weight maintenance in overweight or obese adults.
Jurgens TM, Whelan AM, Killian L, Doucette S, Kirk S, Foy E. Cochrane Database Syst Rev. 2012 Dec 12;12:CD008650. doi: 10.1002/14651858.CD008650.pub2. PubMed PMID: 23235664.


Effects of body size and hypertension treatments on cardiovascular event rates: subanalysis of the ACCOMPLISH randomised controlled trial.
Weber MA, Jamerson K, Bakris GL, Weir MR, Zappe D, Zhang Y, Dahlof B, Velazquez EJ, Pitt B. Lancet. 2013 Feb 16;381(9866):537-45. doi: 10.1016/S0140-6736(12)61343-9. Epub 2012 Dec 6. PubMed PMID: 23219284.


Effect of testosterone replacement on response to sildenafil citrate in men with erectile dysfunction: a parallel, randomized trial.
Spitzer M1, Basaria S, Travison TG, Davda MN, Paley A, Cohen B, Mazer NA, Knapp PE, Hanka S, Lakshman KM, Ulloor J, Zhang A, Orwoll K, Eder R, Collins L, Mohammed N, Rosen RC, DeRogatis L, Bhasin S. Ann Intern Med. 2012 Nov 20;157(10):681-91. doi: 10.7326/0003-4819-157-10-201211200-00004. PubMed PMID: 23165659.


Zonisamide for weight reduction in obese adults: a 1-year randomized controlled trial.
Gadde KM, Kopping MF, Wagner HR 2nd, Yonish GM, Allison DB, Bray GA. Arch Intern Med. 2012 Nov 12;172(20):1557-64. doi: 10.1001/2013.jamainternmed.99. PubMed PMID: 23147455.


Prevalence of major cardiovascular risk factors and cardiovascular diseases among Hispanic/Latino individuals of diverse backgrounds in the United States.
Daviglus ML, Talavera GA, Avilés-Santa ML, Allison M, Cai J, Criqui MH, Gellman M, Giachello AL, Gouskova N, Kaplan RC, LaVange L, Penedo F, Perreira K, Pirzada A, Schneiderman N, Wassertheil-Smoller S, Sorlie PD, Stamler J. JAMA. 2012 Nov 7;308(17):1775-84. doi: 10.1001/jama.2012.14517. PubMed PMID: 23117778.


Impaired insulin signaling in human adipocytes after experimental sleep restriction: a randomized, crossover study.
Broussard JL, Ehrmann DA, Van Cauter E, Tasali E, Brady MJ. Ann Intern Med. 2012 Oct 16;157(8):549-57. doi: 10.7326/0003-4819-157-8-201210160-00005. PubMed PMID: 23070488.


Effectiveness of intervention on physical activity of children: systematic review and meta-analysis of controlled trials with objectively measured outcomes (EarlyBird 54).
Metcalf B, Henley W, Wilkin T. BMJ. 2012 Sep 27;345:e5888. doi: 10.1136/bmj.e5888. PubMed PMID: 23044984.


Liver stiffness measurement using XL probe in patients with nonalcoholic fatty liver disease.
Wong VW, Vergniol J, Wong GL, Foucher J, Chan AW, Chermak F, Choi PC, Merrouche W, Chu SH, Pesque S, Chan HL, de Lédinghen V. Am J Gastroenterol. 2012 Dec;107(12):1862-71. doi: 10.1038/ajg.2012.331. Epub 2012 Oct 2. PubMed PMID: 23032979.


Cardiovascular disease risk in healthy children and its association with body mass index: systematic review and meta-analysis.
Friedemann C, Heneghan C, Mahtani K, Thompson M, Perera R, Ward AM. BMJ. 2012 Sep 25;345:e4759. doi: 10.1136/bmj.e4759. PubMed PMID: 23015032.


A trial of sugar-free or sugar-sweetened beverages and body weight in children.
de Ruyter JC, Olthof MR, Seidell JC, Katan MB. N Engl J Med. 2012 Oct 11;367(15):1397-406. doi: 10.1056/NEJMoa1203034. Epub 2012 Sep 21. PubMed PMID: 22998340.


A randomized trial of sugar-sweetened beverages and adolescent body weight.
Ebbeling CB, Feldman HA, Chomitz VR, Antonelli TA, Gortmaker SL, Osganian SK, Ludwig DS. N Engl J Med. 2012 Oct 11;367(15):1407-16. doi: 10.1056/NEJMoa1203388. Epub 2012 Sep 21. PubMed PMID: 22998339.


Surgical vs conventional therapy for weight loss treatment of obstructive sleep apnea: a randomized controlled trial.
Dixon JB, Schachter LM, O'Brien PE, Jones K, Grima M, Lambert G, Brown W, Bailey M, Naughton MT. JAMA. 2012 Sep 19;308(11):1142-9. PubMed PMID: 22990273.


Health care use during 20 years following bariatric surgery.
Neovius M, Narbro K, Keating C, Peltonen M, Sjöholm K, Agren G, Sjöström L, Carlsson L. JAMA. 2012 Sep 19;308(11):1132-41. PubMed PMID: 22990272.


Exercise dose and diabetes risk in overweight and obese children: a randomized controlled trial.
Davis CL, Pollock NK, Waller JL, Allison JD, Dennis BA, Bassali R, Meléndez A, Boyle CA, Gower BA. JAMA. 2012 Sep 19;308(11):1103-12. PubMed PMID: 22990269.


CYP2E1 and oxidant stress in alcoholic and non-alcoholic fatty liver disease.
Leung TM, Nieto N. J Hepatol. 2013 Feb;58(2):395-8. doi: 10.1016/j.jhep.2012.08.018. Epub 2012 Aug 28. PubMed PMID: 22940046.


Intragastric balloon significantly improves nonalcoholic fatty liver disease activity score in obese patients with nonalcoholic steatohepatitis: a pilot study.
Lee YM, Low HC, Lim LG, Dan YY, Aung MO, Cheng CL, Wee A, Lim SG, Ho KY. Gastrointest Endosc. 2012 Oct;76(4):756-60. doi: 10.1016/j.gie.2012.05.023. Epub 2012 Jul 27. PubMed PMID: 22840293.


Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome.
Vrieze A1, Van Nood E, Holleman F, Salojärvi J, Kootte RS, Bartelsman JF, Dallinga-Thie GM, Ackermans MT, Serlie MJ, Oozeer R, Derrien M, Druesne A, Van Hylckama Vlieg JE, Bloks VW, Groen AK, Heilig HG, Zoetendal EG, Stroes ES, de Vos WM, Hoekstra JB, Nieuwdorp M. Gastroenterology. 2012 Oct;143(4):913-6.e7. doi: 10.1053/j.gastro.2012.06.031. Epub 2012 Jun 20.. PubMed PMID: 22728514.


The diagnosis and management of non-alcoholic fatty liver disease: Practiceguideline by the American Association for the Study of Liver Diseases, AmericanCollege of Gastroenterology, and the American Gastroenterological Association.
Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, Charlton M,Sanyal AJ; American Association for the Study of Liver Diseases; American College of Gastroenterology; American Gastroenterological Association., Am J Gastroenterol. 2012 Jun;107(6):811-26. doi: 10.1038/ajg.2012.128.


Guidelines for liver transplantation for patients with non-alcoholicsteatohepatitis.
Newsome PN, Allison ME, Andrews PA, Auzinger G, Day CP, Ferguson JW, Henriksen PA, Hubscher SG, Manley H, McKiernan PJ, Millson C, Mirza D, Neuberger JM, Oben J, Pollard S, Simpson KJ, Thorburn D, Tomlinson JW, Wyatt JS; British Transplant Society., Gut. 2012 Apr;61(4):484-500. doi: 10.1136/gutjnl-2011-300886. Epub 2012 Jan 10.


Prevalence of risk factors for non-communicable diseases in prison populationsworldwide: a systematic review.
Herbert K, Plugge E, Foster C, Doll H., Lancet. 2012 May 26;379(9830):1975-82. doi: 10.1016/S0140-6736(12)60319-5. Epub 2012 Apr 20.


[Hypophosphatasia of adults disclosed by an isolated joint chondrocalcinosis].
[Article in French], Presse Med. 1986 Nov 8;15(39):1976-7.


Changes in diet and lifestyle and long-term weight gain in women and men.
Mozaffarian D, Hao T, Rimm EB, Willett WC, Hu FB., N Engl J Med. 2011 Jun 23;364(25):2392-404.